Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "67bf0034775083781cf09da8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sodium Sulfate(17.5G), Potassium Sulfate(3.13G), Magnesium Sulfate(1.6G)", "description": "CONSTIKLEAR BOWEL KIT is a specially formulated bowel cleansing solution designed for colonoscopy preparation, bowel cleansing before surgery, and treating severe constipation. It contains a balanced combination of Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate, which work together as an osmotic laxative to ensure complete bowel evacuation. This kit is commonly prescribed to clear the intestines for medical procedures, providing an effective and safe cleansing process.\n\nKey Ingredients\n1. Sodium Sulfate (17.5G)\n✔ Acts as an osmotic laxative, drawing water into the intestines to soften stools and promote bowel movements.\n✔ Helps in rapid and complete colon cleansing.\n\n2. Potassium Sulfate (3.13G)\n✔ Aids in maintaining electrolyte balance while ensuring a smooth bowel-cleansing process.\n✔ Prevents dehydration caused by fluid loss during bowel preparation.\n\n3. Magnesium Sulfate (1.6G)\n✔ Relaxes intestinal muscles, improving bowel motility.\n✔ Supports the natural excretion process for effective cleansing.\n\nKey Benefits\n✅ Complete Bowel Cleansing – Effectively clears the intestines for medical procedures like colonoscopy.\n✅ Fast-Acting Laxative – Promotes quick and efficient bowel movements.\n✅ Safe & Balanced Formula – Maintains electrolyte balance while preventing dehydration.\n✅ Ideal for Colonoscopy Preparation – Ensures a clean colon for accurate medical examination.\n✅ Effective for Severe Constipation – Helps relieve stubborn constipation by softening stool and promoting smooth evacuation.\n✅ Non-Irritating & Gentle – Works efficiently without causing excessive discomfort or cramping.\n\nHow Does It Work?\nCONSTIKLEAR BOWEL KIT works by utilizing osmotic action to draw water into the intestines, which softens stool and triggers bowel movements. Sodium sulfate, potassium sulfate, and magnesium sulfate collectively create a hyperosmotic effect, leading to complete bowel evacuation. This process ensures the colon is free of waste, making it ideal for medical procedures like colonoscopy and bowel surgery.\n\nDirections for Use\n🔹 Dosage & Administration: Follow the exact instructions provided by your healthcare professional.\n🔹 Mix the solution in the prescribed amount of water before consumption.\n🔹 Drink in divided doses as per medical guidance (usually split into two doses before the procedure).\n🔹 Stay Hydrated – Drink plenty of clear fluids to avoid dehydration.\n🔹 Avoid solid foods for several hours before and after consumption.\n\nSide Effects\nWhile generally safe, CONSTIKLEAR BOWEL KIT may cause some mild side effects, including:\n⚠ Nausea or bloating\n⚠ Mild abdominal cramps\n⚠ Diarrhea (expected as part of the cleansing process)\n⚠ Electrolyte imbalance (rare, if not properly hydrated)\n⚠ Dizziness or dehydration in sensitive individuals\n\nIf severe dehydration, irregular heartbeat, or persistent vomiting occurs, seek medical attention immediately.", "price": 465.0, "discountamount": 140.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "clear fluids", "divided doses", "draw water", "clean colon", "sensitive individuals", "prescribed amount", "waste making", "softens stool", "softening stool", "fluid loss", "soften stools", "commonly prescribed", "magnesium sulfate", "balanced combination", "medical guidance", "consumption drink", "osmotic laxative", "medical procedures", "process ensures", "preventing dehydration ideal", "colonoscopy preparation ensures", "medical procedures providing", "bowel surgery directions", "consumption side effects", "utilizing osmotic action", "natural excretion process", "properly hydrated dizziness", "mild side effects", "healthcare professional mix", "exact instructions provided", "dosage administration follow", "complete bowel evacuation", "hyperosmotic effect leading", "causing excessive discomfort", "maintaining electrolyte balance", "treating severe constipation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2062, "imageuri": "https://productimages.withfloats.com/actual/67bf0059873dad0a01776e15.png", "tileimageuri": "https://productimages.withfloats.com/tile/67bf0059873dad0a01776e15.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-26T11:51:16.461Z", "updatedon": "2025-02-26T11:51:51Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sodium-sulfate-17-5g-potassium-sulfate-3-13g-magnesium-sulfate-1-6g-/2062", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CONSTIKLEAR BOWEL KIT", "category": "GASTROLOGYRANGE", "tags": [ "Sodium Sulfate(17.5G)", "Potassium Sulfate(3.13G)", "Magnesium Sulfate(1.6G)", "BOWEL PREPARATION KIT" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67122e4d3a73cc5cb26a04de", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sacubitril (12 mg), Valsartan (13 mg)", "description": "SACUSMART 25 is a potent medication used in the treatment of chronic heart failure. It combines two essential active ingredients, Sacubitril (12 mg) and Valsartan (13 mg), working synergistically to improve heart function and reduce the risk of hospitalization due to heart failure. This combination medication belongs to the class of drugs known as ARNI (Angiotensin Receptor-Neprilysin Inhibitors) and is widely prescribed to manage heart failure symptoms, enhance quality of life, and prolong survival in patients with reduced ejection fraction.\n\n \n\nKey Benefits:\n \n\nImproves Heart Function: SACUSMART 25 enhances the ability of the heart to pump blood more efficiently, reducing symptoms of heart failure such as breathlessness and fatigue.\n\nReduces Hospitalization Risk: By improving heart function and preventing fluid buildup, SACUSMART 25 significantly reduces the likelihood of heart failure-related hospitalizations.\n\nLowers Blood Pressure: The combination of Sacubitril and Valsartan effectively lowers blood pressure, which helps reduce the strain on the heart and prevent further complications.\n\nEnhances Quality of Life: By managing the symptoms of heart failure, SACUSMART 25 helps patients lead a more active and comfortable life.\n\nLong-term Survival: Studies show that the combination therapy of Sacubitril and Valsartan can improve survival rates in patients with chronic heart failure compared to traditional therapies.\n\n \n\nHow Does It Work?\n \n\nSACUSMART 25 works by targeting two critical pathways in the regulation of blood pressure and heart function:\n\nSacubitril’s Role: As a neprilysin inhibitor, Sacubitril prevents the breakdown of natriuretic peptides, which are proteins that promote blood vessel dilation, sodium excretion, and reduced blood pressure. This leads to a decreased workload on the heart, allowing it to function more efficiently and with less strain.\n\nValsartan’s Role: Valsartan, as an angiotensin II receptor blocker, inhibits the action of angiotensin II, a hormone responsible for vasoconstriction (narrowing of blood vessels). By blocking this effect, Valsartan helps blood vessels remain relaxed, improving blood flow and reducing blood pressure.\n\nTogether, these mechanisms improve cardiac function, reduce blood pressure, and enhance the overall cardiovascular health of patients with heart failure.\n\n \n\nDirections for Use:\n \nDosage: SACUSMART 25 should be taken exactly as prescribed by a healthcare provider, typically once or twice daily, depending on the severity of the heart condition.\n\nAdministration: The tablet should be swallowed whole with water, with or without food. It's important not to crush or chew the tablet as this could affect the release and absorption of the medication.\n\nMissed Dose: If a dose is missed, take it as soon as possible unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one.\n\nRegular Monitoring: Patients should regularly monitor their blood pressure and kidney function, as SACUSMART 25 can lower blood pressure significantly and may affect kidney health.\n\n \n\nSide Effects:\n \n\nWhile SACUSMART 25 is generally well-tolerated, some individuals may experience side effects. It’s important to be aware of these potential reactions and consult a doctor if they occur.\n\nCommon Side Effects:\nLow blood pressure (hypotension)\nDizziness or lightheadedness\nElevated potassium levels (hyperkalemia)\nCough\nFatigue\n", "price": 165.0, "discountamount": 49.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "blood flow", "less strain", "Key Benefits", "Cough Fatigue", "fluid buildup", "blood vessels", "kidney health", "survival rates", "heart function", "kidney function", "heart condition", "comfortable life", "cardiac function", "sodium excretion", "potent medication", "ejection fraction", "Long-term Survival", "Regular Monitoring", "Low blood pressure", "combination therapy", "potential reactions", "healthcare provider", "next scheduled dose", "Common Side Effects", "Hospitalization Risk", "natriuretic peptides", "traditional therapies", "chronic heart failure", "blood vessel dilation", "two critical pathways", "combination medication", "heart failure symptoms", "Elevated potassium levels", "overall cardiovascular health", "angiotensin II receptor blocker", "two essential active ingredients", "heart failure-related hospitalizations", "Angiotensin Receptor-Neprilysin Inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1995, "imageuri": "https://productimages.withfloats.com/actual/67122e531e1ad5a3231ccd27.png", "tileimageuri": "https://productimages.withfloats.com/tile/67122e531e1ad5a3231ccd27.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-18T09:45:49.363Z", "updatedon": "2024-10-18T09:45:49.363Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacubitril-12-mg-valsartan-13-mg-/1995", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SACUSMART 25 ", "category": "CARDIOLOGYRANGE", "tags": [ "Sacubitril/valsartan", "sacubitril/valsartan tablets 50 mg uses", "Sacubitril Valsartan brands in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c10e66641561b0446977f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VELAXFINE XR 37.5 ", "description": "VELAXFINE XR 37.5 \nVenlafaxine (37.5mg)\nIntroduction:\n\nVELAXFINE XR 37.5 contains Venlafaxine, an extended-release (XR) formulation designed to treat major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder. With a dosage strength of 37.5mg, VELAXFINE XR 37.5 provides sustained therapeutic effects, significantly improving the quality of life for patients.\nKey Features and Benefits:\n\nAntidepressant Action:\n\nVELAXFINE XR 37.5 is a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in the brain, which helps improve mood and alleviate symptoms of depression.\nAnxiety Relief:\n\nVenlafaxine is effective in treating various anxiety disorders. It reduces the symptoms of anxiety, including excessive worry, restlessness, and physical symptoms such as palpitations and sweating.\nExtended-Release Formulation:\n\nThe extended-release formulation ensures a steady release of medication over 24 hours, providing consistent symptom relief and reducing the need for multiple daily doses. This improves adherence to the treatment regimen and enhances overall effectiveness.\nImproved Quality of Life:\n\nBy effectively managing symptoms of depression and anxiety, VELAXFINE XR 37.5 helps patients regain control of their lives, enhancing their ability to function socially and professionally.\nWell-Tolerated and Safe:\n\nVELAXFINE XR 37.5 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of depression and anxiety disorders.\nDosage and Administration:\n\nInitial Dosage for Depression and Anxiety:\n\nThe recommended starting dose of VELAXFINE XR 37.5 for adults is 37.5mg once daily, taken in the morning or evening. The dose may be increased gradually based on the patient's response and tolerability.\nMaintenance Dosage:\n\nThe usual maintenance dose ranges from 75mg to 225mg per day. Dosage adjustments should be made in increments of 37.5mg to 75mg at intervals of no less than 4 days.\nAdministration Instructions:\n\nVELAXFINE XR 37.5 capsules should be swallowed whole with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of symptoms, response to treatment, and potential side effects is essential during VELAXFINE XR 37.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/velaxfine-xr-37-5-134393", "price": 58.0, "discountamount": 17.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "SAD", "day", "GAD", "food", "life", "SNRI", "mood", "75mg", "need", "EMAIL", "water", "brain", "lives", "225mg", "37.5mg", "levels", "adults", "option", "control", "ability", "evening", "morning", "response", "patients", "Benefits", "sweating", "24 hours", "adherence", "intervals", "increments", "medication", "depression", "Venlafaxine", "information", "restlessness", "palpitations", "sterispharma", "sterisonline", "Introduction", "Key Features", "CALL/WHATSAPP", "starting dose", "panic disorder", "Initial Dosage", "patient safety", "steady release", "Anxiety Relief", "excessive worry", "dosage strength", "Improved Quality", "physical symptoms", "treatment regimen", "Regular monitoring", "Dosage adjustments", "Maintenance Dosage", "therapeutic efficacy", "Continued Monitoring", "multiple daily doses", "long-term management", "Antidepressant Action", "overall effectiveness", "usual maintenance dose", "potential side effects", "social anxiety disorder", "favorable safety profile", "VELAXFINE XR 37.5 therapy", "various anxiety disorders", "consistent symptom relief", "major depressive disorder", "VELAXFINE XR 37.5 capsules", "gastrointestinal discomfort", "Administration Instructions", "Extended-Release Formulation", "generalized anxiety disorder", "sustained therapeutic effects", "serotonin-norepinephrine reuptake inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1910, "imageuri": "https://productimages.withfloats.com/actual/667d14c6ba7e6420d2a4fd30.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d14c6ba7e6420d2a4fd30.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:44:06.065Z", "updatedon": "2024-06-27T07:29:09.447Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/velaxfine-xr-37-5-/1910", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VELAXFINE XR 37.5 ", "category": "NEUROLOGY RANGE", "tags": [ "venlafaxine 37.5 mg", "VELAXFINE XR 37.5", "", "VELAXFINE XR 37.5 side effects", "venlafaxine 37.5mg used for", "venlafaxine urinary side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c07d66641561b044696cc", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TARPEDO ER 50 ", "description": "TARPEDO ER 50 \nTapentadol HCL ER Tablets, (50mg)\nIntroduction:\n\nTARPEDO ER 50 contains Tapentadol HCL, an extended-release (ER) formulation designed for the management of moderate to severe chronic pain. With a dosage strength of 50mg, TARPEDO ER 50 provides sustained pain relief, improving the quality of life for patients who require long-term pain management.\nKey Features and Benefits:\n\nDual Mechanism of Action:\n\nOpioid Agonist: Tapentadol acts as a mu-opioid receptor agonist, providing potent analgesic effects by altering the perception of pain in the central nervous system.\nNorepinephrine Reuptake Inhibitor: It also inhibits the reuptake of norepinephrine, enhancing pain inhibition in the brain and spinal cord, contributing to its analgesic properties.\nExtended-Release Formulation:\n\nTARPEDO ER 50 is designed for extended release, ensuring a steady release of medication over a 12-hour period. This provides consistent pain control and reduces the need for frequent dosing.\nEffective Pain Management:\n\nSuitable for managing various types of chronic pain, including neuropathic pain, osteoarthritis, and lower back pain. TARPEDO ER 50 helps patients maintain daily activities and improve their overall quality of life.\nReduced Side Effects:\n\nCompared to other opioids, Tapentadol has a lower incidence of common opioid-related side effects such as nausea, vomiting, and constipation, making it a more tolerable option for long-term use.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended starting dose of TARPEDO ER 50 is 50mg twice daily, approximately every 12 hours. Dosage should be adjusted based on individual patient response and tolerability.\nTitration and Maintenance:\n\nThe dose may be increased in increments of 50mg every 3 days as needed to achieve adequate pain control. The maximum recommended dose is 500mg per day.\nAdministration Instructions:\n\nSwallow TARPEDO ER 50 tablets whole with water. Do not crush, chew, or split the tablets to avoid rapid release of the drug, which can increase the risk of adverse effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tarpedo-er-50-133971", "price": 148.0, "discountamount": 44.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "50mg", "life", "risk", "drug", "need", "Order", "EMAIL", "water", "500mg", "brain", "Action", "nausea", "option", "patients", "Benefits", "vomiting", "12 hours", "Titration", "medication", "perception", "increments", "information", "Maintenance", "spinal cord", "moderate to", "Introduction", "sterispharma", "sterisonline", "constipation", "tolerability", "Key Features", "CALL/WHATSAPP", "rapid release", "starting dose", "other opioids", "various types", "long-term use", "12-hour period", "osteoarthritis", "Initial Dosage", "Opioid Agonist", "steady release", "Dual Mechanism", "lower back pain", "pain inhibition", "lower incidence", "adverse effects", "overall quality", "dosage strength", "frequent dosing", "neuropathic pain", "daily activities", "extended release", "severe chronic pain", "analgesic properties", "Reduced Side Effects", "sustained pain relief", "adequate pain control", "central nervous system", "consistent pain control", "potent analgesic effects", "maximum recommended dose", "long-term pain management", "Tapentadol HCL ER Tablets", "Effective Pain Management", "mu-opioid receptor agonist", "individual patient response", "Administration Instructions", "Extended-Release Formulation", "Swallow TARPEDO ER 50 tablets", "Norepinephrine Reuptake Inhibitor", "extended-release (ER) formulation", "common opioid-related side effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1903, "imageuri": "https://productimages.withfloats.com/actual/666c07da0b4fc76a99a41803.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c07da0b4fc76a99a41803.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:05:26.681Z", "updatedon": "2024-06-26T06:23:02.343Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tarpedo-er-50-/1903", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TARPEDO ER 50 ", "category": "NEUROLOGY RANGE", "tags": [ "TARPEDO ER 50", "", "Tapentadol HCL ER Tablets, (50mg)", "", "tapentadol 50 mg side effects", "long-term side effects of tapentadol" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c06e12a9e3612903d86ea", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TARPEDO ER 100 ", "description": "TARPEDO ER 100 \nTapentadol HCL ER Tablets (100mg)\nIntroduction:\n\nTARPEDO ER 100 contains Tapentadol HCL, an extended-release (ER) formulation designed to manage moderate to severe chronic pain. With a dosage strength of 100mg, TARPEDO ER 100 offers sustained pain relief, improving the quality of life for patients who require long-term pain management.\nKey Features and Benefits:\n\nDual Mechanism of Action:\n\nOpioid Agonist: Tapentadol acts as a mu-opioid receptor agonist, providing potent analgesic effects by altering the perception of pain in the central nervous system.\nNorepinephrine Reuptake Inhibitor: It also inhibits the reuptake of norepinephrine, enhancing pain inhibition in the brain and spinal cord, which contributes to its analgesic properties.\nExtended-Release Formulation:\n\nTARPEDO ER 100 is designed for extended release, ensuring a steady release of medication over a 12-hour period. This provides consistent pain control and reduces the need for frequent dosing.\nEffective Pain Management:\n\nSuitable for managing various types of chronic pain, including neuropathic pain, osteoarthritis, and lower back pain. TARPEDO ER 100 helps patients maintain daily activities and improve their overall quality of life.\nReduced Side Effects:\n\nCompared to other opioids, Tapentadol has a lower incidence of common opioid-related side effects such as nausea, vomiting, and constipation, making it a more tolerable option for long-term use.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended starting dose of TARPEDO ER 100 is 100mg twice daily, approximately every 12 hours. Dosage should be adjusted based on individual patient response and tolerability.\nTitration and Maintenance:\n\nThe dose may be increased in increments of 50mg to 100mg every 3 days as needed to achieve adequate pain control. The maximum recommended dose is 500mg per day.\nAdministration Instructions:\n\nSwallow TARPEDO ER 100 tablets whole with water. Do not crush, chew, or split the tablets to avoid rapid release of the drug, which can increase the risk of adverse effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/tarpedo-er-100-133972", "price": 278.0, "discountamount": 83.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "need", "50mg", "drug", "risk", "life", "EMAIL", "water", "Order", "500mg", "100mg", "brain", "nausea", "Action", "option", "Benefits", "vomiting", "patients", "12 hours", "Titration", "medication", "increments", "perception", "spinal cord", "Maintenance", "information", "moderate to", "Introduction", "sterisonline", "constipation", "tolerability", "sterispharma", "Key Features", "CALL/WHATSAPP", "rapid release", "other opioids", "starting dose", "various types", "long-term use", "Opioid Agonist", "Dual Mechanism", "steady release", "12-hour period", "osteoarthritis", "Initial Dosage", "overall quality", "dosage strength", "lower incidence", "frequent dosing", "pain inhibition", "adverse effects", "lower back pain", "extended release", "neuropathic pain", "daily activities", "severe chronic pain", "analgesic properties", "Reduced Side Effects", "sustained pain relief", "adequate pain control", "central nervous system", "consistent pain control", "potent analgesic effects", "maximum recommended dose", "Effective Pain Management", "long-term pain management", "Tapentadol HCL ER Tablets", "mu-opioid receptor agonist", "Administration Instructions", "individual patient response", "Extended-Release Formulation", "Swallow TARPEDO ER 100 tablets", "Norepinephrine Reuptake Inhibitor", "extended-release (ER) formulation", "common opioid-related side effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1902, "imageuri": "https://productimages.withfloats.com/actual/666c06e4117f82c50b0d0236.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666c06e4117f82c50b0d0236.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:01:21.805Z", "updatedon": "2024-06-26T06:25:00.472Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tarpedo-er-100-/1902", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TARPEDO ER 100 ", "category": "NEUROLOGY RANGE", "tags": [ "long-term side effects of tapentadol", "tapentadol er 100 mg", "TARPEDO ER100", "tapentadol 50 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c060caebebd090016591c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SUMOTROP NPX ", "description": "SUMOTROP NPX \nSumatriptan (85mg), Naproxen (500mg)\nIntroduction:\n\nSUMOTROP NPX combines Sumatriptan and Naproxen to offer powerful, dual-action relief for acute migraine attacks. Sumatriptan, a selective serotonin receptor agonist, and Naproxen, a nonsteroidal anti-inflammatory drug (NSAID), work together to alleviate migraine symptoms quickly and effectively, helping patients regain control of their lives.\nKey Features and Benefits:\n\nDual-Action Relief:\n\nSumatriptan (85mg): Targets serotonin (5-HT1) receptors to constrict dilated blood vessels in the brain, reducing headache pain and associated symptoms like nausea and sensitivity to light and sound.\nNaproxen (500mg): Reduces inflammation and pain through its action as an NSAID, providing additional relief and prolonging the effect of Sumatriptan.\nRapid and Long-Lasting Relief:\n\nThe combination of Sumatriptan and Naproxen ensures rapid onset of action, relieving migraine symptoms quickly. The anti-inflammatory properties of Naproxen also help maintain pain relief for a longer duration.\nComprehensive Symptom Management:\n\nSUMOTROP NPX addresses multiple migraine symptoms, including headache pain, nausea, and sensitivity to light and sound, providing comprehensive symptom relief.\nImproved Quality of Life:\n\nBy effectively managing migraine attacks, SUMOTROP NPX enables patients to resume their daily activities with minimal disruption, enhancing overall quality of life.\nWell-Tolerated and Safe:\n\nThis combination medication is generally well-tolerated, offering a favorable safety profile for patients needing acute migraine treatment.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended dose of SUMOTROP NPX is one tablet containing Sumatriptan (85mg) and Naproxen (500mg) taken orally at the first sign of a migraine attack.\nMaximum Dosage:\n\nDo not exceed two tablets in a 24-hour period. If the migraine returns after initial relief, a second dose may be taken at least 2 hours after the first dose.\nAdministration Instructions:\n\nSwallow the tablet whole with water. Taking the medication with food may help reduce gastrointestinal side effects associated with Naproxen.\nContinued Monitoring:\n\nRegular monitoring of migraine frequency, severity, and response to treatment is essential to optimize therapy and ensure patient safety.For further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/sumotrop-npx-133632", "price": 104.95, "discountamount": 31.48, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "85mg", "food", "Life", "Order", "lives", "EMAIL", "NSAID", "light", "sound", "water", "brain", "500mg", "nausea", "control", "product", "therapy", "severity", "response", "patients", "Naproxen", "Benefits", "first dose", "first sign", "one tablet", "rapid onset", "sensitivity", "two tablets", "information", "Sumatriptan", "second dose", "pain relief", "inflammation", "Introduction", "sterispharma", "SUMOTROP NPX", "sterisonline", "Key Features", "headache pain", "CALL/WHATSAPP", "Maximum Dosage", "Initial Dosage", "initial relief", "24-hour period", "patient safety", "longer duration", "overall quality", "Improved Quality", "daily activities", "additional relief", "migraine frequency", "Regular monitoring", "minimal disruption", "associated symptoms", "Long-Lasting Relief", "Continued Monitoring", "dilated blood vessels", "acute migraine attacks", "combination medication", "favorable safety profile", "acute migraine treatment", "multiple migraine symptoms", "Administration Instructions", "serotonin (5-HT1) receptors", "anti-inflammatory properties", "powerful, dual-action relief", "comprehensive symptom relief", "gastrointestinal side effects", "Comprehensive Symptom Management", "nonsteroidal anti-inflammatory drug", "selective serotonin receptor agonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1901, "imageuri": "https://productimages.withfloats.com/actual/666c060f492d7ea0aba1c9f3.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c060f492d7ea0aba1c9f3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T08:57:48.703Z", "updatedon": "2024-06-29T12:24:01.982Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sumotrop-npx-/1901", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SUMOTROP NPX ", "category": "NEUROLOGY RANGE", "tags": [ "sumatriptan injection buy", "Naproxen (500mg)", "Sumatriptan (85mg)", "Sumatriptan (85mg),", "sumotrop npx uses in hindi", "sumotrop npx price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c03124cb45413344ec7be", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SUMATROPH 50 ", "description": "SUMATROPH 50 \nSumatriptan succinate Rapid- Release (50mg)\nIntroduction:\n\nSUMATROPH 50 contains Sumatriptan succinate, a selective serotonin receptor agonist (triptan) used for the acute treatment of migraine attacks. With a dosage strength of 50mg in a rapid-release formulation, SUMATROPH 50 offers quick and effective relief from the debilitating symptoms of migraines, helping patients regain control over their daily lives.\nKey Features and Benefits:\n\nRapid-Release Formulation:\n\nSUMATROPH 50 is designed to provide rapid relief from migraine symptoms. Its quick absorption and onset of action help alleviate headache pain, nausea, and sensitivity to light and sound within a short period.\nTargeted Action:\n\nSumatriptan succinate specifically targets serotonin (5-HT1) receptors in the brain, leading to the constriction of dilated blood vessels, which is believed to be a primary cause of migraine pain. This targeted action effectively reduces the intensity and duration of migraine attacks.\nSymptom Relief:\n\nSUMATROPH 50 not only alleviates headache pain but also helps relieve associated migraine symptoms such as nausea, vomiting, and photophobia (sensitivity to light) or phonophobia (sensitivity to sound), providing comprehensive symptom relief.\nImproved Quality of Life:\n\nBy providing quick and effective relief from migraines, SUMATROPH 50 enables patients to resume their daily activities with minimal disruption, enhancing their overall quality of life.\nWell-Tolerated and Safe:\n\nSumatriptan is generally well-tolerated, with a favorable safety profile, making SUMATROPH 50 a reliable option for the acute treatment of migraines.\nDosage and Administration:\n\nInitial Dosage:\n\nThe recommended dose of SUMATROPH 50 for adults is 50mg taken orally at the first sign of a migraine attack. The dose may be increased to 100mg if needed, based on individual response and tolerability.\nMaximum Dosage:\n\nDo not exceed 200mg in a 24-hour period. If the migraine returns after initial relief, a second dose may be taken at least 2 hours after the first dose.\nAdministration Instructions:\n\nSwallow SUMATROPH 50 tablets whole with water. The rapid-release formulation ensures quick absorption and onset of action.\nContinued Monitoring:\n\nRegular monitoring of migraine frequency, severity, and response to treatment is essential to optimize therapy and ensure patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/sumatroph-50-133683", "price": 148.4, "discountamount": 44.52, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Life", "50mg", "light", "100mg", "onset", "sound", "brain", "200mg", "Order", "water", "EMAIL", "adults", "nausea", "option", "therapy", "control", "duration", "severity", "patients", "vomiting", "Benefits", "intensity", "migraines", "first sign", "first dose", "sensitivity", "second dose", "photophobia", "daily lives", "phonophobia", "information", "constriction", "Introduction", "sterisonline", "tolerability", "Key Features", "short period", "rapid relief", "sterispharma", "primary cause", "headache pain", "CALL/WHATSAPP", "migraine pain", "patient safety", "24-hour period", "Initial Dosage", "Maximum Dosage", "initial relief", "acute treatment", "dosage strength", "Targeted Action", "overall quality", "effective relief", "quick absorption", "Improved Quality", "daily activities", "migraine attacks", "minimal disruption", "Regular monitoring", "migraine frequency", "individual response", "Continued Monitoring", "debilitating symptoms", "dilated blood vessels", "favorable safety profile", "rapid-release formulation", "serotonin (5-HT1) receptors", "Administration Instructions", "Swallow SUMATROPH 50 tablets", "associated migraine symptoms", "comprehensive symptom relief", "Sumatriptan succinate Rapid- Release", "selective serotonin receptor agonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1900, "imageuri": "https://productimages.withfloats.com/actual/666c03182d43284d72746dc6.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c03182d43284d72746dc6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T08:45:06.277Z", "updatedon": "2024-06-29T12:24:49.64Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sumatroph-50-/1900", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SUMATROPH 50 ", "category": "NEUROLOGY RANGE", "tags": [ "SUMATROPH 50", "", "sumatriptan 50 mg tablet uses", "Sumatriptan succinate Rapid- Release (50mg)", "sumatriptan side effects", "sumatriptan 50 mg tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be6b8aa93342004eef58f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 2 ", "description": "ROPINPRIME 2 \nRopinirole (2mg)\nIntroduction:\n\nRopinprime 2 is a medication containing Ropinirole, a potent dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 2mg, Ropinprime 2 is designed to effectively alleviate symptoms by mimicking dopamine's action in the brain, thus improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 2 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This action helps reduce motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 2 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 2 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 2mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 2 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 2 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 2 therapy to ensure therapeutic efficacy and patient safety.\n\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-2-133629", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "RLS", "1mg", "8mg", "life", "aids", "food", "brain", "Order", "EMAIL", "0.5mg", "water", "0.25mg", "action", "nausea", "bedtime", "disease", "tremors", "patients", "Benefits", "condition", "Parkinson", "stiffness", "Ropinirole", "likelihood", "medication", "information", "Introduction", "bradykinesia", "independence", "tolerability", "initial dose", "sterisonline", "sterispharma", "greater ease", "Key Features", "CALL/WHATSAPP", "sleep quality", "starting dose", "motor symptoms", "patient safety", "multiple doses", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "patient response", "symptom severity", "daily activities", "clinical response", "Maintenance doses", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "2mg dosage strength", "Ropinprime 2 therapy", "healthcare providers", "therapeutic efficacy", "Continued Monitoring", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "uncomfortable sensations", "flexible dosing regimens", "individual patient needs", "Administration Instructions", "Swallow Ropinprime 2 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1895, "imageuri": "https://productimages.withfloats.com/actual/667d15dbce74849f89cdd68a.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d15dbce74849f89cdd68a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:44:08.261Z", "updatedon": "2024-06-27T07:33:46.566Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-2-/1895", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 2 ", "category": "NEUROLOGY RANGE", "tags": [ "Ropinirole (2mg)", "ROPINPRIME 2", "ropinirole side effects", "ropinirole side effects: weight gain", "ropinirole side effects in elderly" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be5a070774b1f84f699ad", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 1 ", "description": "ROPINPRIME 1 \nRopinirole (1mg)\nIntroduction:\n\nRopinprime 1 contains Ropinirole, a potent dopamine agonist used primarily to treat Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 1mg, Ropinprime 1 is designed to alleviate symptoms by mimicking the action of dopamine in the brain, thereby improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 1 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This mechanism helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 1 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 1 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 1mg dosage strength provides flexibility in dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 1 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 1 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 1 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/ropinprime-1-133628", "price": 124.0, "discountamount": 37.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "day", "8mg", "life", "food", "EMAIL", "water", "0.5mg", "Order", "brain", "nausea", "action", "0.25mg", "bedtime", "disease", "tremors", "patients", "Benefits", "movement", "mechanism", "condition", "Parkinson", "stiffness", "medication", "likelihood", "Ropinirole", "flexibility", "information", "bradykinesia", "independence", "tolerability", "Introduction", "sterisonline", "initial dose", "sterispharma", "Key Features", "greater ease", "CALL/WHATSAPP", "starting dose", "sleep quality", "motor symptoms", "Initial Dosage", "multiple doses", "patient safety", "symptom control", "treatment plans", "dosing regimens", "Flexible Dosing", "overall comfort", "symptom severity", "patient response", "daily activities", "Maintenance doses", "clinical response", "dopamine receptors", "Regular monitoring", "1mg dosage strength", "uncontrollable urge", "Continued Monitoring", "therapeutic efficacy", "healthcare providers", "Ropinprime 1 therapy", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "Administration Instructions", "Swallow Ropinprime 1 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1894, "imageuri": "https://productimages.withfloats.com/actual/666be5a4475de163fe91643d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be5a4475de163fe91643d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:39:28.983Z", "updatedon": "2024-06-26T07:04:00.123Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-1-/1894", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 1 ", "category": "NEUROLOGY RANGE", "tags": [ "ROPINPRIME 1", "ropinirole side effects in elderly", "ropinirole side effects", "ropinirole warnings" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
13 hours?

Still searching for
13 hours?

Chat with us